Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)

NCT00633217 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Fluticasone Propionate/Salmeterol DISKUS 250/50mcg
DRUG: Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg

Sponsor

GlaxoSmithKline